Law Firm Probes Option Care Health Amid Shareholder Concerns
Monteverde & Associates PC has opened an investigation into Option Care Health, a NASDAQ-listed home infusion company, on behalf of shareholders.
A New York-based class action law firm has launched an investigation into Option Care Health, Inc. (NASDAQ: OPCH), signaling potential legal scrutiny over the company's corporate actions, according to an announcement released October 11, 2026.
Monteverde & Associates PC, led by class action attorney Juan Monteverde, disclosed the probe targeting the home infusion and specialty pharmacy provider. The firm described itself as a recognized Top 50 firm in the 2025 ISS Securities Class Action Services Report and said it has previously recovered millions of dollars for shareholders in similar cases.
Read more Retail Investing Platforms Hit 41M Accounts in Record Quarter →
The investigation's precise focus was not detailed in the initial announcement, which is typical in early-stage shareholder inquiries that often precede merger-related or fiduciary duty litigation. Such probes generally examine whether company executives and board members fulfilled their obligations to shareholders in connection with major corporate transactions or disclosures.
Option Care Health operates as one of the largest independent providers of home and alternate-site infusion services in the United States, making any significant corporate development a matter of interest to a broad base of retail and institutional investors. Shareholders who believe they may be affected are typically encouraged to contact the investigating firm directly to understand their legal options.
Continue reading at All Financial Services & Investing.
